Filter
1506
Filtered Results: 1506
Text search:
drug
approval
Featured
Recommendations
105
New Publications
446
Language
Document type
No document type
913
Studies & Reports
253
Guidelines
186
Manuals
64
Strategic & Response Plan
35
Fact sheets
28
Training Material
15
Situation Updates
5
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
India
99
Kenya
47
Uganda
46
Global
42
Nigeria
39
South Africa
37
Malawi
35
Ethiopia
32
Nepal
32
Sierra Leone
30
Western and Central Europe
29
Myanmar / Burma
26
Liberia
25
Ukraine
25
Ghana
24
Bangladesh
24
Zambia
23
Tanzania
22
Rwanda
19
Latin America and the Carribbean
19
Namibia
17
Lesotho
17
Africa
15
Zimbabwe
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
10
Burkina Faso
9
Senegal
8
Philippines
8
Cambodia
8
Asia
8
Syria
6
Thailand
6
Tajikistan
6
Russia
6
USA
5
Pakistan
5
Mozambique
5
Benin
5
Cameroon
4
South Sudan
4
Germany
4
China
4
Indonesia
4
Peru
4
East and Southern Africa
4
Venezuela
4
Albania
4
Afghanistan
3
Eswatini/ Swaziland
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Georgia
3
Vietnam
3
Guinea
2
Somalia
2
Iraq
2
Central African Republic
2
Brazil
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Western Pacific Region
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Haiti
1
Lebanon
1
Turkey
1
Sudan
1
Argentina
1
Colombia
1
Libya
1
Madagascar
1
Sri Lanka
1
Chile
1
Yemen
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Southern Africa
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
662
Clinical Guidelines
127
Public Health
52
Women & Child Health
41
Pharmacy & Technologies
36
Key Resources
26
Capacity Building
12
Toolboxes
HIV
179
TB
142
AMR
111
COVID-19
82
Mental Health
79
Pharmacy
71
NTDs
42
Ebola
29
NCDs
28
Rapid Response
26
Caregiver
25
Planetary Health
17
Conflict
13
Global Health Education
13
Refugee
12
Health Financing Toolbox
12
Disability
11
Polio
6
Zika
6
Natural Hazards
5
Specific Hazards
4
Cholera
2
Social Ethics
1
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Nutrition data and information systems (ND&IS) are critical to guide the prioritisation, collection, analysis and
dissemination of nutrition data in countries. However, there is limited guidance for countries regarding how to invest
in their ND&IS and little is known about current financing alloca...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
While epidemiological data for type 1 diabetes (T1D) in low/middle-income countries, and particularly low-income countries (LICs) including Liberia is lacking, prevalence in LICs is thought to be increasing. T1D care in LICs is often impacted by challenges in diagnosis and management. These challeng...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
Background: Community health worker (CHW) programmes are a valuable component of primary care in resource-poor settings. The evidence supporting their effectiveness generally shows improvements in disease-specific outcomes relative to the absence of a CHW programme. In this study, we evaluated expan...
Since the Alma Ata Declaration in 1978, community health volunteers (CHVs) have been at the forefront, providing health services, especially to underserved communities, in low-income countries. However, consolidation of CHVs position within formal health systems has proved to be complex and continue...
People with disabilities experience significant health inequalities. In Malawi, where most individuals live in low-income rural settings, many of these inequalities are exacerbated by restricted access to health care services. This qualitative study explores the barriers to health care access experi...
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3.2 million children with SAM have access to treatme...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy...
Health systems in Latin America face many challenges in controlling the increasing burden of diabetes. Digital health interventions are a promise for the provision of care, especially in developing countries where mobile technology has a high penetration. This study evaluated the effectiveness of th...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
World Health Organization. (2022). Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 4: developing an implementation plan.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
